Press Releases
Endo Presents Data at the American Orthopaedic Foot & Ankle Society Annual Meeting
ENDO ANNOUNCES CEO TRANSITION
ENDO REPORTS SECOND-QUARTER 2024 FINANCIAL RESULTS
Endo Presents New Data at the American Podiatric Medical Association Annual Meeting
Endo to Host Investor Call on Second Quarter 2024 Financial Results
Endo Announces Effectiveness of Form S-1 Registration Statement for Existing Shares
Endo Releases Annual Corporate Responsibility Report
Endo USA, Inc. Issues Voluntary, Nationwide Recall of One Lot of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Lot Number 550147301 Due to Mislabeling: Incorrect Strength on Product Carton
Endo Launches Tiopronin Delayed-Release Tablets, Generic Version of THIOLA EC®
Endo Files Registration Statement with SEC, Advancing Planned Move to NYSE